Senior Associate
Complex Commercial Litigation
Reese’s principal area of practice is complex civil and criminal antitrust litigation, representing clients in class action antitrust cases, including multidistrict litigation. Reese represents clients in the pharmaceutical, healthcare, aerospace and defense, consumer goods and energy sectors in a wide range of antitrust matters, including criminal and civil litigation and merger and nonmerger antitrust investigations conducted by the Federal Trade Commission, United States Department of Justice, and state attorneys general. Reese assists companies in responding to Second Requests and Civil Investigative Demands and also counsels clients on compliance with the Sherman Act, Clayton Act, FTC Act, Robinson-Patman Act, resale price maintenance/minimum advertised price laws, and other pertinent antitrust laws.
Reese also advises on the full gamut of federal and state consumer protection compliance issues including advertising, endorsements, customer reviews, labeling, claim substantiation, subscriptions, TCPA, Made in the USA claims, and federal and state promotional pricing and sales regulations.
Reese maintains an active pro bono practice, both representing clients in affirmative asylum proceedings and defending clients in removal proceedings before Executive Office for Immigration Review immigration judges.
Defended an American multinational technology company in various lawsuits against claims of false advertising and violation of state unfair competition statutes
Defended two defendants in multidistrict litigation involving allegations that generic pharmaceutical manufacturers conspired to increase the price of generic pharmaceuticals in violation of Section 1 of the Sherman Act In re Generic Pharmaceuticals Antitrust Litigation
Defended healthcare executive, ultimately acquitted on all charges, in first-ever criminal no-poach trial and ongoing follow-on civil putative class action
Education
Admissions
Client Alerts
FTC’s FY 2026-2030 Strategic Plan: Strong Enforcement Signals Despite Business-Friendly Tone
By Jason Powers, Adam Hudes, Nicole Castle, Reese Poncia, and Stephen Creighton* Overview The Federal Trade Commission (“FTC”) recently issued …
July 21, 2026
July 21, 2026 • 3-minute read
Event Recaps
This program provided in-house counsel with a practical, issue-spotting framework for identifying and managing the antitrust, consumer protection, and securities litigation risks that arise from corporate ESG and sustainability initiatives.
May 14, 2026
May 14, 2026 • 1-minute read
Firm News
Vinson & Elkins Attorneys Recognized on 2025 Capital Pro Bono Honor Roll
The District of Columbia Courts have recognized 12 Vinson & Elkins attorneys on the 2025 Capital Pro Bono Honor Roll, …
May 4, 2026
May 4, 2026 • 1-minute read
our People
Please note that any communication with Vinson & Elkins via e-mail through this website does not constitute or create an attorney-client relationship with V&E. Please do not send any confidential information. A conflicts-of-interest procedure must be completed by V&E prior to establishment of an attorney-client relationship. When you execute an engagement letter from V&E you will be our client, and you may then exchange information freely with a V&E attorney.
By clicking “Accept,” you agree that we may review any information you transmit to us. You recognize that our review of your information, even if it is highly confidential and even if it is transmitted in a good faith effort to retain us, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you.
